Quality assurance in the EORTC randomized trial 22922/10925 investigating the role of irradiation of the internal mammary and medial supraclavicular lymph node chain works

Strahlentherapie und Onkologie

Volumn 182, Issue 10, 2006, Pages 576-582

  Poortmans, Philip ^a   Kouloulias, Vassilis ^b   Van Tienhoven, Geertjan ^c   Collette, Laurence ^d   Struikmans, Henk ^e   Venselaar, Jack L M ^a   Van Den Bogaert, Walter ^f   Davis, J Bernard ^g   Lambin, Philippe ^h  

^a DR BERNARD VERBEETEN INSTITUTE   (Netherlands)

^b UH Attikon   (Greece)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d EORTC DATA CENTER   (Belgium)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^h MAASTRO CLINIC   (Netherlands)

Author keywords

Breast cancer; Internal mammary chain; Quality assurance; Radiotherapy; Randomized clinical trial

Indexed keywords

ACCURACY; ANATOMY; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; HEALTH CARE ORGANIZATION; HUMAN; LYMPH NODE IRRADIATION; QUALITY CONTROL; RANDOMIZATION; TREATMENT OUTCOME; TREATMENT PLANNING;

BREAST NEOPLASMS; EUROPE; FEMALE; HUMANS; LYMPHATIC METASTASIS; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; QUALITY ASSURANCE, HEALTH CARE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33749250797     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-006-1629-2     Document Type: Article

References (24)

1. Bolla M, Bartelink H, Garavaglia G, et al. EORTC guidelines for writing protocols for clinical trials of radiotherapy. Radiother Oncol 1995;36:1-8.
2. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366:2087-106.
3. Fodor J, Polgar C, Major T, et al. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation. The significance of tumor size. Strahlenther Onkol 2003;179:197-202.
4. Gomola I, Van Dam J, Isern-Verdum J, et al. External audits of electron beams using mailed TLD dosimetry: preliminary results. Radiother Oncol 2001;58:163-8.
5. Grabenbauer GG. Internal mammary nodes in invasive breast carcinoma. To treat or not to treat? Strahlenther Onkol 2004;180:690-4.
6. Gruber G, Berclaz G, Altermatt HJ, et al. Can the addition of regional radiotherapy counterbalance important risk factors in breast cancer patients with extracapsular invasion of axillary lymph node metastases? Strahlenther Onkol 2003;179:661-6.
7. Højris I, Overgaard M, Christensen JJ, et al. Morbidity and mortality of ischemic heart disease in high-risk breast-cancer patients after adjuvant post-mastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82B and 82C randomised trials. Lancet 1999;354:1425-30.
8. Hurkmans CW, Borger JH, Bos LJ, et al. Cardiac and lung complication probabilities after breast cancer irradiation. Radiother Oncol 2000;55:145-51.
9. ICRU Report 50. Prescribing, recording and reporting photon beam therapy. Bethesda: International Commission on Radiation Units and Measurements, 1993.
10. ICRU Report 62. Prescribing, recording and reporting photon beam therapy (Supplement to ICRU Report 50). Bethesda: International Commission on Radiation Units and Measurements, 1999.
11. Kouloulias VE, Poortmans PM, Bernier J, et al. The quality assurance programme of the Radiotherapy Group of the European Organisation for Research and Treatment of Cancer (EORTC): a critical appraisal of 20 years of continuous efforts. Eur J Cancer 2003;39:430-7.
12. Lievens Y, Poortmans P, Van den Bogaert W. A glance on quality assurance in EORTC study 22922 evaluating techniques for internal mammary and medial supraclavicular lymph node chain irradiation in breast cancer. Radiother Oncol 2001;60:257-65.
13. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997;337:949-55.
14. Overgaard M, Jensen M-J, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999;353:1641-8.
15. Pierce LJ, Richer AS. Postmastectomy radiotherapy: more than locoregional control. J Clin Oncol 1994;12:444-6.
16. Poortmans P, Kouloulias VE, Venselaar JL, et al. Quality assurance of EORTC trial 22922/10925 investigating the role of internal mammary - medial supraclavicular irradiation in stage I-III breast cancer: the individual case review. Eur J Cancer 2003;39:2035-42.
17. Poortmans PMP, Venselaar JLM, Struikmans H, et al. The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: a quality-assurance report on the dummy run of EORTC phase III randomized trial 22922/10925 in stage I-III breast cancer. Int J Radiat Oncol Biol Phys 2001;49:1399-408.
18. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:956-62.
19. Stranzl H, Mayer R, Ofner P, et al. Extracapsular extension in positive axillary lymph nodes in female breast cancer patients. Patterns of failure and indications for postoperative locoregional irradiation. Strahlenther Onkol 2004;180:31-7.
20. Stranzl H, Peintinger F, Ofner P, et al. Regional nodal recurrence in the management of breast cancer patients with one to three positive axillary lymph nodes. Outcome of patients following tangential irradiation without a separate nodal field. Strahlenther Onkol 2004;180:623-8.
21. Struikmans H, van Rijk PP. Optimizing radiotherapy of the internal mammary chain in breast carcinoma by scintigraphy. Radiother Oncol 1996;41:15-20.
22. Van den Bogaert W, Struikmans H, Fourquet A, et al. Internal mammary and medial supraclavicular (IM-MS) lymph node chain irradiation in stage I-III breast cancer. A phase III randomised trial of the EORTC, protocol 22922/10925, May 1996, revision May 1999. Brussels: EORTC Data Centre.
23. Van Tienhoven G, Mijnheer BJ, Bartelink H, et al. Quality assurance of the EORTC trial 22881/10882:boost versus no boost in breast conserving therapy. An overview. Strahlenther Onkol 1997;173:201-7.
24. Whelan TJ, Julian J, Wright J, et al. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 2000;18:1220-9.